Strategic Insight
We help you understand what the market actually wants, and align your positioning with what partners and investors need to hear.
Partnering and BD support designed for early‑stage biotech
A deal acceleration system: from strategy to deal outcomes
Helping biotechs achieve more than $1B in deal value over the last three years
The problem
Strong science isn't enough.
You've built something worth paying attention to. But the right people aren't paying attention, or the conversations aren't going anywhere.
It's rarely just one thing. The positioning doesn't resonate with what partners actually want. The outreach isn't reaching the right decision-makers. And when meetings do happen, there's no clear path from conversation to outcome.
Underneath the activity, there's a harder question most founders don't say out loud:are we even doing the right things?
Who we are
We've been on the other side of the table.
We've sat alongside founders facing exactly these challenges.
Our team has worked across big pharma, biotech, healthcare, and consulting. We've had visibility into how partnering and investment decisions are made, and we've helped shape them from multiple sides of the table.
We've supported more than 30 biotech innovators, enabling hundreds of partnering and investment discussions and facilitating deals exceeding $1 billion in combined value.
We're not here to replace you. We're here to make sure your science reaches its full potential.
Services
How we help
Strategy, access, and execution in one place.
Targeted Access
We connect you with decision-makers who are relevant and capable of acting. Not a list of names. Targeted engagement with people who matter for your programme and stage.
Execution
We run the process. Outreach, meeting preparation, negotiation support, and deal progression: the BD capability most early-stage companies don't have in-house.
You can engage us for strategic support at a specific inflection point, or as an integrated BD partner across the full journey.
The model flexes to where you are.
How it works
A clear path from positioning to deals
Position
Build the strategy and roadmap that take you from where you stand today to a signed deal.
Engage
Identify and get connected to the right decision-makers across pharma and investor networks.
Refine
Sharpen your positioning and strategy continuously, against real feedback from the market.
Progress
Turn early engagement into structured discussions, negotiations, and deal progression.
See where you stand
Find out how ready your company is for structured partnering, and where the gaps might be.
Outcomes
Where this takes you
- Your positioning is clear. Partners understand what you do and why it matters.
- You're in conversations with the right people, not just anyone who'll take a meeting.
- Those conversations are progressing. There's momentum, follow-up, and a visible path forward.
- You have strategic clarity on your data, your development plan, and your options.
- And instead of wondering whether you're doing the right things, you know you are.
Take action
Every month without clarity, the window narrows.
Runway gets spent without building toward an outcome. Opportunities pass. Partners move on.
Early-stage companies that delay structured BD don't just lose time. They lose opportunities, and the chance to shape conversations on their terms.
FAQ
Frequently asked questions
We're too early for BD. Should we wait?
Most companies engage us earlier than they expect to. Even before active outreach, getting your positioning right and understanding what the market wants can shape critical decisions, from indication selection to data strategy. The earlier you align, the less you have to correct later.
How is this different from hiring a BD consultant or advisor?
Most advisors offer either strategy or introductions. Rarely both, and almost never with structured execution. We combine strategic insight, a relevant network, and hands-on BD support in a single system. We don't just tell you what to do. We help you do it.
What's the benefit of working with you versus doing this ourselves?
Three things you can't easily replicate in-house. First, we have direct access to insight from partners and investors: what they're looking for, how they evaluate opportunities, and what's holding them back. Second, we provide the bandwidth to run a structured BD process so it doesn't stall alongside everything else you're managing. And third, we bring an established network paired with strong processes to get you in front of the right people efficiently.
We have limited budget. Is this realistic for us?
We work with early-stage companies at different stages of funding. Our engagement models are flexible, and we're transparent about what's realistic given your resources. The greater cost is usually an unstructured process that uses up runway without producing a deal.
What outcomes can we expect?
That depends on your stage, your data, and your objectives. What we can say is that our system is designed to generate clear positioning, relevant conversations, and structured progress toward partnerships, funding, or acquisition. We don't promise deals. We build the conditions that make them possible.
Next step
Find out where you stand
Not sure if your company is positioned to partner effectively? Tell us where your programme is and we'll tell you what we see.
Contact us
Email info@probacure.com and we'll come back to you.